Anti-B3GALT1 antibodies are used in the immunodetection of the protein beta-1,3-galactosyltransferase 1. In humans, the canonical protein has a reported length of 326 amino acid residues and a mass of 38 kDa. Its subcellular localization is in the Golgi. It is notably expressed in the brain and colon mucosa and to a lesser extent in colon adenocarcinoma cells. A member of the Glycosyltransferase 31 protein family, B3GALT1 is a reported Beta-1,3-galactosyltransferase that transfers galactose from UDP-alpha-D-galactose to substrates with a terminal beta-N-acetylglucosamine (beta-GlcNAc) residue. Synonyms for this target antigen include UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1, UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1, beta-1,3-GalTase 1, beta3GalT1, and beta3Gal-T1. B3GALT1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Western Blot is a widely used application for the B3GALT1 antibodies listed below. In addition, ELISA is also a common application.